GSK Raises 2024 Targets Amid Strong Cancer and HIV Treatment Sales

Pharmaceutical giant reports significant growth in Q2, while HSBC announces $3bn buyback and Bank of Japan hikes rates.

GSK's Q2 sales rose by 13%, driven by a 22% increase in specialty medicine sales and a doubling of oncology sales.
HSBC revealed a $3bn share buyback plan and set a new 2025 target for mid-teens return on average tangible equity.
The Bank of Japan raised interest rates to 0.25%, marking its second hike in 17 years and signaling further increases if economic conditions align.
Oil prices increased due to geopolitical tensions following the assassination of a Hamas leader in Iran.
Taylor Wimpey's half-year profit dropped by over 58%, reflecting the UK's housing market slowdown.